急性动静脉通道血栓形成经皮穿刺取栓的疗效。

IF 1.6 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE
Sellers Boudreau, Anthony Grzeda, Adam Hicks, Jessica Schucht, Erik Wayne, Amit Dwivedi, Abindra Sigdel
{"title":"急性动静脉通道血栓形成经皮穿刺取栓的疗效。","authors":"Sellers Boudreau, Anthony Grzeda, Adam Hicks, Jessica Schucht, Erik Wayne, Amit Dwivedi, Abindra Sigdel","doi":"10.1016/j.avsg.2025.09.025","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study was to determine outcomes after percutaneous aspiration thrombectomy of acutely thrombosed arteriovenous dialysis access.</p><p><strong>Methods: </strong>A retrospective review of 78 patients undergoing a total of 146 percutaneous aspiration thrombectomies of arteriovenous dialysis access between 2016 to 2020 were reviewed to evaluate outcomes. The CAT-D Suction Thrombectomy Device (Penumbra; Alameda, CA) was the device used to restore arteriovenous access patency in this study. Outcomes measured include rates of successful thrombectomy, primary patency rates, and cumulative patency rates were determined via chart review. Secondary analysis was conducted to determine factors that may affect post procedure patency.</p><p><strong>Results: </strong>Seventy-eight patients undergoing a total of 146 percutaneous aspiration thrombectomies were studied. There was a technical success rate of 98.6% with 95.9% subsequently undergoing dialysis successfully. There were no procedural related deaths or clinically apparent pulmonary embolism. Primary patency at 30, 90, and 180 days was 58.2%, 35.6%, and 23.3% with an average primary patency of 104.5 days. Cumulative patency rates at 30, 90, and 180 days were 80.8%, 64.4%, and 54.8% with an average cumulative patency rate of 232.5 days.</p><p><strong>Conclusions: </strong>The use of percutaneous aspiration thrombectomy in acutely thrombosed arteriovenous access is associated with high technical and clinical success rates while maintaining a low risk of complications. This study demonstrated a primary and cumulative patency rate that was lower than prior literature, but this may have been secondary to our study population consisting of greater numbers of patients with known risk factors for early access thrombosis.</p>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Outcomes of Percutaneous Aspiration Thrombectomy in Acute Thrombosis of Arteriovenous Access.\",\"authors\":\"Sellers Boudreau, Anthony Grzeda, Adam Hicks, Jessica Schucht, Erik Wayne, Amit Dwivedi, Abindra Sigdel\",\"doi\":\"10.1016/j.avsg.2025.09.025\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>The objective of this study was to determine outcomes after percutaneous aspiration thrombectomy of acutely thrombosed arteriovenous dialysis access.</p><p><strong>Methods: </strong>A retrospective review of 78 patients undergoing a total of 146 percutaneous aspiration thrombectomies of arteriovenous dialysis access between 2016 to 2020 were reviewed to evaluate outcomes. The CAT-D Suction Thrombectomy Device (Penumbra; Alameda, CA) was the device used to restore arteriovenous access patency in this study. Outcomes measured include rates of successful thrombectomy, primary patency rates, and cumulative patency rates were determined via chart review. Secondary analysis was conducted to determine factors that may affect post procedure patency.</p><p><strong>Results: </strong>Seventy-eight patients undergoing a total of 146 percutaneous aspiration thrombectomies were studied. There was a technical success rate of 98.6% with 95.9% subsequently undergoing dialysis successfully. There were no procedural related deaths or clinically apparent pulmonary embolism. Primary patency at 30, 90, and 180 days was 58.2%, 35.6%, and 23.3% with an average primary patency of 104.5 days. Cumulative patency rates at 30, 90, and 180 days were 80.8%, 64.4%, and 54.8% with an average cumulative patency rate of 232.5 days.</p><p><strong>Conclusions: </strong>The use of percutaneous aspiration thrombectomy in acutely thrombosed arteriovenous access is associated with high technical and clinical success rates while maintaining a low risk of complications. This study demonstrated a primary and cumulative patency rate that was lower than prior literature, but this may have been secondary to our study population consisting of greater numbers of patients with known risk factors for early access thrombosis.</p>\",\"PeriodicalId\":8061,\"journal\":{\"name\":\"Annals of vascular surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-09-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of vascular surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.avsg.2025.09.025\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of vascular surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.avsg.2025.09.025","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

摘要

目的:本研究的目的是确定急性血栓形成的动静脉透析通路经皮穿刺取栓后的结果。方法:回顾性分析2016年至2020年间78例动静脉透析通路经皮穿刺取栓术患者,共146例。CAT-D抽吸取栓装置(Penumbra; Alameda, CA)是本研究中用于恢复动静脉通道通畅的装置。测量的结果包括成功取栓率、原发性通畅率和累积通畅率,通过图表回顾确定。进行二次分析以确定可能影响术后通畅的因素。结果:78例经皮穿刺取栓术患者共146例。技术成功率为98.6%,术后透析成功率为95.9%。无手术相关死亡或临床明显的肺栓塞。30、90和180天的初发通畅率分别为58.2%、35.6%和23.3%,平均初发通畅为104.5天。30、90、180 d累计通畅率分别为80.8%、64.4%、54.8%,平均累计通畅率为232.5 d。结论:在急性血栓形成的动静脉通路中使用经皮穿刺取栓术具有较高的技术和临床成功率,同时保持较低的并发症风险。该研究显示原发性和累积的通畅率低于先前的文献,但这可能是继发性的,因为我们的研究人群中有更多已知早期血栓形成危险因素的患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Outcomes of Percutaneous Aspiration Thrombectomy in Acute Thrombosis of Arteriovenous Access.

Objective: The objective of this study was to determine outcomes after percutaneous aspiration thrombectomy of acutely thrombosed arteriovenous dialysis access.

Methods: A retrospective review of 78 patients undergoing a total of 146 percutaneous aspiration thrombectomies of arteriovenous dialysis access between 2016 to 2020 were reviewed to evaluate outcomes. The CAT-D Suction Thrombectomy Device (Penumbra; Alameda, CA) was the device used to restore arteriovenous access patency in this study. Outcomes measured include rates of successful thrombectomy, primary patency rates, and cumulative patency rates were determined via chart review. Secondary analysis was conducted to determine factors that may affect post procedure patency.

Results: Seventy-eight patients undergoing a total of 146 percutaneous aspiration thrombectomies were studied. There was a technical success rate of 98.6% with 95.9% subsequently undergoing dialysis successfully. There were no procedural related deaths or clinically apparent pulmonary embolism. Primary patency at 30, 90, and 180 days was 58.2%, 35.6%, and 23.3% with an average primary patency of 104.5 days. Cumulative patency rates at 30, 90, and 180 days were 80.8%, 64.4%, and 54.8% with an average cumulative patency rate of 232.5 days.

Conclusions: The use of percutaneous aspiration thrombectomy in acutely thrombosed arteriovenous access is associated with high technical and clinical success rates while maintaining a low risk of complications. This study demonstrated a primary and cumulative patency rate that was lower than prior literature, but this may have been secondary to our study population consisting of greater numbers of patients with known risk factors for early access thrombosis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.00
自引率
13.30%
发文量
603
审稿时长
50 days
期刊介绍: Annals of Vascular Surgery, published eight times a year, invites original manuscripts reporting clinical and experimental work in vascular surgery for peer review. Articles may be submitted for the following sections of the journal: Clinical Research (reports of clinical series, new drug or medical device trials) Basic Science Research (new investigations, experimental work) Case Reports (reports on a limited series of patients) General Reviews (scholarly review of the existing literature on a relevant topic) Developments in Endovascular and Endoscopic Surgery Selected Techniques (technical maneuvers) Historical Notes (interesting vignettes from the early days of vascular surgery) Editorials/Correspondence
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信